The largest database of trusted experimental protocols

Protease and phosphate inhibitors

Manufactured by Roche
Sourced in Germany

Protease and phosphate inhibitors are laboratory reagents used to inhibit the activity of specific enzymes, such as proteases and phosphatases, in various experimental settings. These inhibitors are designed to prevent the degradation or modification of target molecules, allowing for the preservation of their structural and functional integrity during experimental procedures.

Automatically generated - may contain errors

5 protocols using protease and phosphate inhibitors

1

Protein Quantification in Testis Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tissue samples of testis were homogenized in an ice-cold RIPA buffer containing protease and phosphate inhibitors (Roche Applied Science, Penzberg, Germany). The concentration of protein in the supernatant was measured using the bicichonic acid assay after centrifugation at 13,000 g for 15 mint, protein samples 10μl were loaded onto SDS-PAGE gels at 4-12%. Electrophoresis was performed at 120 V for 2 hr at 4° C (Bio-Red Mini-Protein), followed by immunoblotting with primary antibodies dilution (1:1000) and Actin (1:10,000) (Table 2). Targeted proteins intensities CD63, LC3, P62 and LAMP2 were normalized against actin. Western blotting quantitative measurements were performed in three independent experiments.
+ Open protocol
+ Expand
2

Autophagy Pathway Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small intestinal tissue samples were homogenized in ice-cold radio immunoprecipitation assay (RIPA) buffer that contained protease and phosphate inhibitors (Roche Applied Science, Penzberg, Germany). After centrifugation at 13,000× g for 15 min, the protein concentration in the supernatant was quantified with the bicinchoninic acid protein assay (Thermo Scientified). Protein samples (45 µg) were loaded on 4–12% SDS–PAGE gels. Electrophoresis was run at 120 V for 2 h at 4 °C (Bio-Red Mini-Protean), and immunoblotting was performed with primary antibodies (diluted 1:1000) and β-actin (1:10,000; Bioworld, Nanjing, China). The intensities of target proteins LC3, p62, PINK1, and AMPK were normalized against β-actin. Three independent experiments were performed for western blotting quantification analysis.
+ Open protocol
+ Expand
3

Western Blot Analysis of Kif7 in MEFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed in PBS and lysed in 1X RIPA (Millipore) with protease and phosphate inhibitors (Roche). Lysates were cleared by centrifugation, and protein concentration was determined using the Pierce BCA Protein Assay Kit (Thermo Scientific). Fifteen to twenty micrograms of protein was boiled in 2X sample buffer and then resolved on 4–12% gels (Biorad). Protein was transferred to nitrocellulose (GE Healthcare) and blocked in TBS-T (0.1% tween) with 5% milk for at least 1 hour. Primary antibodies were added overnight in blocking buffer. The following days blots were washed for 1 hour in TBS-T, and then secondary antibodies were added in blocking buffer for 1 hour. Blotted protein was visualized using Thermo ECL reagents. Western blots performed on serum starved MEFs were performed by pooling several 10 Cm dishes of approximately 0.7*106 cells (40–60% confluent) control and Kif7 mutant MEFs due to low protein concentrations. Cell fractionation was performed as described by [53 (link)]. Co-immunoprecipitation of GFP-fused KIF7 was performed using the GFP trap kit (Chromotek) according to the manufacturer instructions. Quantification of bands from immunoblots was performed using Image J software.
+ Open protocol
+ Expand
4

Western Blot Analysis of BZN-Treated 143B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
143B cells were treated with different concentrations of BZN (4, 5, 6, or 7 µM) and DMSO for 24 h, and then lysed with RIPA cell lysis buffer (Boster, Wuhan, China) supplemented with 1% protease and phosphate inhibitors (Roche, Basel, Switzerland). Protein samples were separated by 10% sodium dodecyl sulfate-PAGE gel and transferred onto PVDF membranes. After blocking with 5% BSA for 2 h, the membranes were incubated with the corresponding primary antibodies (1:1000 dilution) at 4 °C overnight, followed by incubation with horseradish peroxidase-conjugated secondary antibody (1:5000 dilution) at 37 °C for an hour. Proteins of interest were visualized with the ECL kit and photographed with a gel imaging system. The gray values of the bands were analyzed with the Image Lab or ImageJ software.
+ Open protocol
+ Expand
5

Monitoring NOD2 K48 Ubiquitination Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Assembling of K48 poly-ubiquitin chains on NOD2 in response to MDP was monitored over time. THP-1 Myc-BirA*-NOD2 cells were pre-treated for one h with DMSO (vehicle) or MG132 (at 12.5 µM) before 10 µg/mL of MDP (InvivoGen, France) was added. At given time points, samples were taken, spun down and the reaction was stopped using RIPA lysis buffer plus protease and phosphate inhibitors (ROCHE, Germany). Additionally, 50 mM of N-ethylmaleimide (Thermofisher scientific, USA) was added to the RIPA buffer to lyse the MG132-treated samples. A SDS gel was run and membranes were blotted against the anti-NOD2monoclonal antibody (2D9) (SantaCruz, sc-56168, 1:250) and RIPK2 (Cell Signalling Technology, USA) and anti-actin (Sigma Aldrich, UK, Cat No. A5060, 1:2000) or anti-Tubulin (Sigma Aldrich, UK, Cat No. T9026, 1:2000) as a controls. NOD2 ubiquitination was assessed using the anti-poly-K48 antibody (Merck Millipore, USA, Cat No. 05-1307, 1:2500).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!